The agreement includes significant milestone payments to Foamix upon the attainment of development, regulatory and clinical goals, with Foamix responsible for the foam formulation development of the products.
Adolor submitted a new drug application to the FDA for Entereg in June 2004, but in July of this year the FDA informed the company that it would
Peramivir is part of a class of antiviral agents that work by inhibiting viral neuraminidase, an enzyme essential for the influenza virus to replicate and infect its hosts.
MT 100 was developed as an oral, first-line treatment for migraine. It is a patented sequential release tablet containing two approved drugs, naproxen sodium, which relieves pain and
In the 23 women who completed the study, ovulation suppression, a widely accepted marker for effective pregnancy prevention, was achieved in 96% of the subjects. Most contraceptive products
The study is designed to determine the optimal dose of Bronchitol and is being conducted in seven hospitals throughout Canada. “This Canadian trial builds on our previously reported
Eniluracil is a drug designed to improve the effectiveness of 5-FU, one of the world’s most commonly used chemotherapies, by inhibiting its breakdown. Adherex in-licensed the drug from
This superior level of performance is particularly important as leading public health agencies continue to express caution about the lack of sensitivity and related performance limitations of currently
The purpose of the studies was to compare the safety of VaxGen’s attenuated vaccine candidate, LC16m8, with that of the unattenuated Lister strain of the vaccine, from which
In March 2005, Coley and Pfizer entered into an exclusive global license agreement to develop, manufacture and commercialize Coley’s PF-3512676, a Toll-like receptor 9 (TLR9) agonist delivered by
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.